. Author manuscript; available in PMC: 2012 Dec 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2011 May 11;17(12):1765–1774. doi: 10.1016/j.bbmt.2011.05.005

Table 3. Multivariate analysis of progression of MM.

	N^*	Hazard Ratio For Progression	95% confidence interval		P-value
Body mass index^†:
No TBI
Normal	244	1.00			P_overall = 0.055
Over-weight	397	0.85	0.70	1.03	0.10
Obese	175	0.87	0.69	1.10	0.25
Severely obese	99	1.18	0.90	1.55	0.23
TBI
Normal	44	1.00			P_overall = 0.027
Over-weight	62	0.96	0.61	1.49	0.84
Obese	20	0.54	0.28	1.03	0.06
Severely obese	22	0.43	0.22	0.86	0.016
Other significant covariates:
Immunochemical subtype
IgG	576	1.00			P_overall = 0.002
IgA	220	1.44	1.20	1.73	<0.001
Light chain	168	1.06	0.86	1.31	0.58
Others	63	0.95	0.69	1.32	0.77
Unknown	36	1.12	0.75	1.70	0.58
Disease status at transplant
CR/PR	812	1.00			P_overall = 0.009
MR/NR/SD	227	1.16	0.97	1.39	0.10
Relapse/progression	24	1.84	1.18	2.86	0.007

Seven patients were excluded from the model for missing information on vital status, and 17 patients being excluded due to missing information on time to progression.

^†

P-value for interaction between BMI and TBI = 0.0085